Literature DB >> 23619591

Echocardiographic assessment of right ventricular function before and after surgery in patients with pectus excavatum and right ventricular compression.

Ufuk Gürkan1, Bülent Aydemir2, Sukru Aksoy1, Haldun Akgöz1, Aydın Rodi Tosu1, Dilaver Öz1, Barış Güngör1, Hale Yılmaz1, Osman Bolca1.   

Abstract

BACKGROUND: We aimed to evaluate the effect of surgical repair on right ventricular (RV) function in patients with pectus excavatum (PE) and RV compression by Doppler echocardiography.
MATERIALS AND METHODS: Twenty-three patients who were admitted to our hospital for surgical correction of PE between 2009 and 2012 were included in the study. After transthoracic echocardiographic evaluation, 16 patients with RV compression were enrolled. All patients were males (100%) with a mean age of 20.5 ± 5.6 years. Transthoracic echocardiography was repeated 1 month after surgery. Echocardiographic evaluation included the assessment of RV diastolic diameter, tricuspid annular plane systolic excursion (TAPSE), pulsed tissue Doppler systolic velocity (S'), RV isovolumic acceleration (RV IVA), systolic pulmonary artery pressure, left ventricular (LV) ejection fraction, and myocardial performance indexes of both the right and the left ventricles (Tei index).
RESULTS: Following the surgery, the RV end-diastolic diameter, TAPSE, S', and RV IVA were found to be significantly increased in patients with PE. In addition, RV and LV Tei index significantly improved after surgical correction.
CONCLUSIONS: RV function significantly improved after corrective surgery. Quantitative echocardiographic examination provides accurate estimation when deciding for corrective surgery and also should be used in the assessment of postoperative improvement. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23619591     DOI: 10.1055/s-0033-1342941

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  8 in total

1.  Improved cardiac function and exercise capacity following correction of pectus excavatum: a review of current literature.

Authors:  Marie Maagaard; Johan Heiberg
Journal:  Ann Cardiothorac Surg       Date:  2016-09

2.  Nuss technique in pectus excavatum: a mono-institutional experience.

Authors:  Hans K Pilegaard
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Diastolic and Systolic Cardiac Dysfunction in Pectus Excavatum: Relationship to Exercise and Malformation Severity.

Authors:  Ignacio M Raggio; Marcelo Martínez-Ferro; Gastón Bellía-Munzón; Carlos Capunay; Martín Munín; Luzía Toselli; Patricia Carrascosa; Gastón A Rodríguez-Granillo
Journal:  Radiol Cardiothorac Imaging       Date:  2020-10-15

4.  Cardiovascular magnetic resonance assessment of biventricular changes during vacuum bell correction of pectus excavatum.

Authors:  Lorenzo Monti; Orsola Montini; Emanuele Voulaz; Marie Maagaard; Emanuela Morenghi; Hans K Pilegaard; Maurizio Infante
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

Review 5.  Outcomes in adult pectus excavatum patients undergoing Nuss repair.

Authors:  MennatAllah M Ewais; Shivani Chaparala; Rebecca Uhl; Dawn E Jaroszewski
Journal:  Patient Relat Outcome Meas       Date:  2018-01-30

6.  Pectus excavatum: Right ventricular compromise with orthostatic syndrome and Brugada phenocopy.

Authors:  Eftychios Siniorakis; Spyridon Arvanitakis; Panagiotis Tzevelekos; Stamatia Panta; Apostolos Balanis; Fotini Aivalioti; Sotiria Limberi
Journal:  J Saudi Heart Assoc       Date:  2017-02-02

7.  Sternal elevation by the crane technique during pectus excavatum repair: A quantitative analysis.

Authors:  Erik R de Loos; Jean H T Daemen; Nadine A Coorens; Jos G Maessen; Yvonne L J Vissers; Karel W E Hulsewé
Journal:  JTCVS Tech       Date:  2021-07-17

8.  Reshaping the Evidence for Surgical Correction of Pectus Excavatum Using Cardiopulmonary Exercise Testing.

Authors:  Ashok Kar; Max Baghai; Ian Hunt
Journal:  J Am Heart Assoc       Date:  2022-04-04       Impact factor: 6.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.